BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 97392)

  • 1. Isotope-release cytotoxicity assay with the use of indium-111: advantage over chromium-51 in long-term assays.
    Wiltrout RH; Frost P; Cummings GD
    J Natl Cancer Inst; 1978 Jul; 61(1):183-8. PubMed ID: 97392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of in vivo natural antitumor resistance and lymphocyte. Migration in mice: comparison of 125I-iododeoxyuridine with 111indium-oxine and 51chromium as cell labels.
    Wiltrout RH; Gorelik E; Brunda MJ; Holden HT; Herberman RB
    Cancer Immunol Immunother; 1983; 14(3):172-9. PubMed ID: 6404550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurements of cell-mediated cytotoxicity on target cells labelled with the indium-111-oxine complex.
    Smet-Donnay M; Guillaume M; Schaaf-Lafontaine N; Czichosz R; Firket H
    Ann Biol Clin (Paris); 1985; 43(3):285-8. PubMed ID: 3161437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of indium-111 for studies of cytotoxicity mediated by lymphocytes or by antibodies and complement.
    Ferluga J; Allison AC; Thakur ML
    J Clin Lab Immunol; 1979 Feb; 1(4):339-42. PubMed ID: 501729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of macrophage-mediated cytotoxicity against adherent and non-adherent target cells by release of 11 indium-oxine.
    Wiltrout RH; Taramelli D; Holden HT
    J Immunol Methods; 1981; 43(3):319-31. PubMed ID: 6788853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An isotope release cytotoxicity assay applicable to human tumors: the use of 111indium.
    Frost P; Wiltrout R; Maciorowski Z; Rose NR
    Oncology; 1977; 34(3):102-4. PubMed ID: 917438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro induction of tumour-specific immunity. I. Development of optimal conditions for induction and assay of cytotoxic lymphocytes.
    Burton R; Thompson J; Warner NL
    J Immunol Methods; 1975; 8(1-2):133-49. PubMed ID: 807654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of clone formation as an assay for T cell-mediated cytotoxicity: short-term kinetics and comparison with 51Cr release.
    Lees RK; MacDonald HR; Sinclair NR
    J Immunol Methods; 1977; 16(3):233-44. PubMed ID: 406330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A modified 51Cr release assay for cytotoxic lymphocytes.
    Dunkley M; Miller RG; Shortman K
    J Immunol Methods; 1974 Dec; 6(1-2):39-51. PubMed ID: 4215833
    [No Abstract]   [Full Text] [Related]  

  • 10. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
    Germain RN; Williams RM; Benacerraf B
    Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of 51Cr release for detecting cell-mediated cytotoxic responses to solid chemically induced rat tumours.
    Zöller M; Price MR; Baldwin RW
    Br J Cancer; 1977 Jun; 35(6):834-43. PubMed ID: 194618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A long-term 51chromium assay for in vitro cell-mediated tumor immunity. Correlation with simultaneously performed microplate assays.
    Steele G; Sjögren HO; Lannerstad O; Stadenberg I
    Int J Cancer; 1975 Oct; 16(4):682-93. PubMed ID: 1176212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 75Se-release: a short and long term assay system for cellular cytoxicity.
    Leibold W; Bridge S
    Z Immunitatsforsch Immunobiol; 1979 Mar; 155(4):287-311. PubMed ID: 463182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardization of the chromium-51 release, cell-mediated cytotoxicity assay: cryopreservation of mouse effector and target cells.
    Holden HT; Oldham RK; Ortaldo JR; Herberman RB
    J Natl Cancer Inst; 1977 Mar; 58(3):611-22. PubMed ID: 839557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indium-III: a new radionuclide label for studying human platelet kinetics.
    Heaton WA; Davis HH; Welch MJ; Mathias CJ; Joist JH; Sherman LA; Siegel BA
    Br J Haematol; 1979 Aug; 42(4):613-22. PubMed ID: 476012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 111Indium labeling of cultured human tumor cells.
    Lockshin A; Mendoza JT; Giovanella BC; Stehlin JS
    Oncology; 1985; 42(5):322-7. PubMed ID: 3929199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of fluorochrome-labeled and 51Cr-labeled targets for natural killer cytotoxicity assay.
    Wierda WG; Mehr DS; Kim YB
    J Immunol Methods; 1989 Aug; 122(1):15-24. PubMed ID: 2760476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell mediated lympholysis; a modified technique using 111indium-oxine-labelled targets.
    Jakubek P; Thorsby E; Hirschberg H
    J Immunol Methods; 1983 Jun; 60(3):379-90. PubMed ID: 6406608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An enzyme-release assay for natural cytotoxicity.
    Korzeniewski C; Callewaert DM
    J Immunol Methods; 1983 Nov; 64(3):313-20. PubMed ID: 6199426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a P815-derived line with an amplified adenosine deaminase gene: an improved target for cellular cytotoxicity.
    Vielh P; Castellazzi M
    Eur J Immunol; 1985 Oct; 15(10):981-5. PubMed ID: 3932081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.